Decode Initiates Phase Iia Clinical Trial For Dg031 deCODE genetics (Nasdaq:DCGN), Reykjavik, Iceland, has initiated its ten-week, information-rich Phase IIa clinical trial of DG031, its developmental compound for the prevention of heart attack. The trial is designed to examine the effect of various doses of DG031 on biomarkers such as C-reactive protein (CRP) and myeloperoxidase […]
Category: Worldwide Biotech
China Certifies Pharmagenesis’ Bone Marrow Stimulant Pg2 China’s State Drug Administration (SDA) has awarded Pharmagenesis Inc., Palo Alto, Calif., a new drug certificate for its plant-derived hematopoiesis enhancer, PG2, bringing the company a step closer to producing and marketing the medicine for patient use. PG2 is an adjunct to cancer therapy that restores activity of […]
Lion Gets New And Upgraded Licenses For Srs LION bioscience AG (Nasdaq: LEON) has expanded its presence in the Italian life science market with new and upgraded licenses for SRS, its industry-leading integration technology for biological data, as well as for its Expression Profiling Solution for better microarray analysis. Financial details were not disclosed. Chiron […]
Cryptome Gets Option For Anti-Inflammatory Drug License Cryptome Pharmaceuticals Ltd, Melbourne, Australia, (ASX:CRP) has signed an agreement with the University of Virginia giving the company sole option to an exclusive license over a novel class of protein-derived compounds with potent anti-inflammatory action. Upon the exercise of the option and finalizing terms, the agreement gives Cryptome […]
National Research Council Of Canada Accepts Automated Lab – Brief Article CRS Robotics Corporation (TSE: ROB) has received on-site acceptance of a new automated laboratory system recently sold to Canada’s National Research Council. The CRS system for NRC’s Plant Biotechnology Institute will be a showpiece of Canadian agricultural genomics. The hybrid system, combining both DNA […]
Mpm Capital Leads Eur22 Million Financing Of Bioxell MPM Capital LP, Boston, has announced that it led a EUR22 million (just under $20 million) financing of BioXell, a spin-out of Hoffmann-La Roche, located in Milan, Italy. MPM General Partners Drs., Michael Steinmetz and Dennis Henner have joined BioXell’s Board of Directors. MPM Capital has invested […]
First Canadian Trial For Xenical Launched Hoffmann-La Roche Limited, Canada, has initiated a clinical trial to evaluate its weight loss medication Xenical(R) (orlistat) in overweight adolescents. Xenical is the only Health Canada-approved prescription medication for adults that reduces the absorption of dietary fat. The new trial will study the safety and efficacy of Xenical in […]
Nanosphere/Takaro Bio Form Develop/Distribute Alliance Nanosphere, Inc., Northbrook, Ill., a privately held nanotechnology-based life sciences company, has signed a letter of intent to form a development and distribution alliance with Takara Bio Inc., one of Japan’s leading biotechnology companies. In the alliance, Takara will have exclusive distribution rights for certain Nanosphere products in Asia and […]
Proligo Debuts Truesnp Primer Kits Based On Lna Proligo LLC, Boulder, Colo., a subsidiary of Degussa AG, has introduced a new product line, TrueSNP(TM) primer kits based on Locked Nucleic Acids (LNA(TM)). These kits are designed to be used for allele-specific PCR, targeting single nucleotide polymorphism (SNP) genotyping. Inclusion of LNA into the primer imparts […]
U.K. Hospital Treats Cancer Patients With Smartbeam Imrt Ipswich Hospital NHS Trust, Ipswich, U.K., has commenced treating cancer patients with a new radiotherapy technique called SmartBeam(TM) IMRT (Intensity Modulated Radiotherapy), a technique that allows more precise targeting of tumors with much less damage to nearby healthy tissues. Clinicians at Ipswich used SmartBeam IMRT for the […]